The climate emergency for rheumatologists: where do we stand?

被引:0
|
作者
Mruthyunjaya, Prakashini [1 ]
Sondur, Suhas [2 ]
Ahmed, Sakir [1 ]
Grainger, Rebecca [3 ]
机构
[1] KIIT Univ, Kalinga Inst Med Sci, Dept Clin Immunol & Rheumatol, Bhubaneswar, India
[2] KIIT Univ, Kalinga Inst Med Sci, Dept Orthopaed, Bhubaneswar, India
[3] Univ Otago, Dept Med, Wellington, New Zealand
关键词
Autoimmunity; Climate change; Epigenetics; Emerging infections; SYSTEMIC-LUPUS-ERYTHEMATOSUS; AIR-POLLUTION EXPOSURES; RHEUMATOID-ARTHRITIS; WEATHER CONDITIONS; ZIKA VIRUS; OXIDATIVE STRESS; CARBON FOOTPRINT; T-CELLS; OSTEOARTHRITIS; CHIKUNGUNYA;
D O I
10.1007/s10067-024-07284-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Climate change and pollution are a major existential threat. Healthcare contributes a noteworthy 4-6% to the total carbon footprint and 5-7% of the total greenhouse gas (GHG) emissions. Environmental pollution and modern lifestyles are also contributing to the increased prevalence of autoimmune and lifestyle-related rheumatic disease. In this review, we assess both the effects of rheumatological practice on climate change and the potential impact of climate change on rheumatological diseases. Preliminary evidence suggests that climate change is linked with the inception or exacerbation of some of the autoimmune and inflammatory rheumatic diseases (AIRDs) like rheumatoid arthritis, lupus, systemic sclerosis, and reactive arthritis. Furthermore, with rampant industrialization and pollution, emerging infections such as Dengue, Zika virus, and chikungunya have emerged as triggers of inflammatory arthritis. Strategies at different levels are proposed to mitigate the effect of the healthcare industry and the community on the environment. The rheumatology community can acknowledge and begin to address the challenges of climate change and health.
引用
收藏
页码:573 / 582
页数:10
相关论文
共 50 条
  • [1] Climate change and desertification: Where do we stand, where should we go?
    Verstraete, Michel M.
    Brink, Andreas B.
    Scholes, Robert J.
    Beniston, Martin
    Smith, Mark Stafford
    GLOBAL AND PLANETARY CHANGE, 2008, 64 (3-4) : 105 - 110
  • [2] TNF inhibition in SLE: where do we stand?
    Aringer, M.
    Smolen, J. S.
    LUPUS, 2009, 18 (01) : 5 - 8
  • [3] Fibrates in hypertension: where do we stand?
    Gremmels, Hendrik
    Joles, Jaap A.
    JOURNAL OF HYPERTENSION, 2018, 36 (05) : 1024 - 1028
  • [4] Genetics of Keratoconus: Where Do We Stand?
    Abu-Amero, Khaled K.
    Al-Muammar, Abdulrahman M.
    Kondkar, Altaf A.
    JOURNAL OF OPHTHALMOLOGY, 2014, 2014
  • [5] Mexican rheumatology: where do we stand?
    Pineda, Carlos
    Sandoval, Hugo
    Fraga-Mouret, Antonio
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (04) : 585 - 593
  • [6] Nurturing longevity through natural compounds: Where do we stand, and where do we go?
    Todorova, Monika N.
    Savova, Martina S.
    Mihaylova, Liliya V.
    Georgiev, Milen I.
    FOOD FRONTIERS, 2024, 5 (02): : 267 - 310
  • [7] Sjogren's syndrome: Where do we stand, and where shall we go?
    Cornec, Divi
    Jamin, Christophe
    Pers, Jacques-Olivier
    JOURNAL OF AUTOIMMUNITY, 2014, 51 : 109 - 114
  • [8] The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
    Agapidou, Alexandra
    Stavrakis, Thomas
    Vlachaki, Efthymia
    Anagnostis, Panagiotis
    Vakalopoulou, Sophia
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (02) : 88 - 93
  • [9] Pesticides and cardiotoxicity. Where do we stand?
    Georgiadis, Nikolaos
    Tsarouhas, Konstantinos
    Tsitsimpikou, Christina
    Vardavas, Alexandros
    Rezaee, Ramin
    Gerrnanakis, Ioannis
    Tsatsakis, Aristides
    Stagos, Dimitrios
    Kouretas, Demetrios
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 353 : 1 - 14
  • [10] Photodynamic Therapy in Melanoma - Where do We Stand?
    Baldea, Ioana
    Giurgiu, Lorin
    Teacoe, Ioana Diana
    Olteanu, Diana Elena
    Olteanu, Florin Catalin
    Clichici, Simona
    Filip, Gabriela Adriana
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (40) : 5540 - 5563